• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH LACTATE DEHYDROGENASE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH LACTATE DEHYDROGENASE Back to Search Results
Model Number 2P56-42
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 01/29/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).An investigation was performed for the customer issue and included a review of the complaint text, a search for similar complaints, a review of trending data, a review of product quality history, and a review of product labeling.The ticket searches determined there were no other complaints similar to the current complaint issue and the tracking and trending report review determined that there are no related trends.Return testing was not completed as returns were not available.Manufacturing documentation was reviewed and did not identify any issues.Labeling was reviewed and found to be adequate.Based on all available information and abbott diagnostics' complaint investigation a product deficiency was not identified.
 
Event or Problem Description
The customer stated that a falsely elevated architect ldh result of 337 u/l was generated for a patient sample that retested at 151 u/l on the same architect analyzer and 132/136 u/l on a different architect analyzer.The customer's normal range is 125 to 220 u/l.No adverse impact to patient management was reported.
 
Additional Manufacturer Narrative
Correction to section d.Suspect medical device was discovered on (b)(6) 2020.The catalog# was submitted as 02p56-42 (wiesbaden, germany manufacturing site) but should be 02p56-21 (irving, texas manufacturing site).See mdr # 1628664-2020-00079 for the correct manufacturing site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LACTATE DEHYDROGENASE
Common Device Name
LACTATE DEHYDROGENASE
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10146006
Report Number3002809144-2020-00471
Device Sequence Number2438522
Product Code CFG
UDI-Device Identifier00380740161477
UDI-Public00380740161477
Combination Product (Y/N)N
Initial Reporter CountryIT
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/22/2020
Device Model Number2P56-42
Device Catalogue Number02P56-21
Device Lot Number04294UN19
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/10/2020
Supplement Date Received by Manufacturer06/10/2020
Initial Report FDA Received Date06/11/2020
Supplement Report FDA Received Date07/03/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARCHITECT C16000 ANALYZER; ARCHITECT C16000 ANALYZER; LN 03L77-01 SN (B)(4); LN 03L77-01 SN (B)(6)
-
-